22 completed, 15 unknown, 3 not yet recruiting, 2 recruiting. 8 Phase 2, 7 Not applicable, 6 Phase 1, 3 Early Phase 1, 2 Phase 3.
Follow Pneumoconiosis: new trials by email Literature Review of Pneumoconiosis trials Research Report on Pneumoconiosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT) - Tobacco Use Cessation, Tobacco Use Disorder | Not applicable | Not yet recruiting | University of Virginia | 120 | 2026-09-01 | 2026-07-10 |
| Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients Modified Qing-Zao-Jiu-Fei Decoction (MQZJFD), Placebo - Pneumoconiosis | Phase 2 | Not yet recruiting | Chinese University of Hong Kong | 80 | 2025-11-01 | 2025-09-17 |
| Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study COPD, Interstitial Pneumonia | Not yet recruiting | Zhejiang University | 250 | 2025-04-22 | 2025-04-22 | |
| Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis Acceptance-based healthy lifestyles program (intervention group), Acceptance-based healthy lifestyles program (control group) - Pneumoconiosis, Healthy Lifestyle | Not applicable | Completed | Chinese University of Hong Kong | 80 | 2024-11-01 | 2026-10-16 |
| Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania No intervention - Silicosis, Tuberculosis | Unknown | National Heart and Lung Institute | 1400 | 2024-03-11 | 2024-05-16 | |
| Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil Silica 12CH - Silicosis | Early Phase 1 | Unknown | HOHM Foundation | 100 | 2024-03-01 | 2024-02-28 |
| Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis Pirfenidone - Asbestosis | Not applicable | Unknown | Cairo University | 40 | 2024-02-01 | 2023-08-30 |
| Reducing Silica Exposure Among Brick Kiln Workers in Nepal N95 Respirator, Protective Eyewear, Baseline Survey - Silicosis | Not applicable | Completed | Johns Hopkins University | 98 | 2024-01-24 | 2024-06-24 |
| Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP) MRI - Iron Deposition, Dialysis | Unknown | GCS Ramsay Santé pour l'Enseignement et la Recherche | 185 | 2022-11-01 | 2022-10-25 | |
| The SHIELD Study-silicosis Silicosis | Unknown | The University of Queensland | 120 | 2022-08-16 | 2022-09-21 | |
| Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials questionnaire, KAP - Silicosis, Silicotic Fibrosis (Massive) of Lung | Unknown | Samuel Hatfield | 995 | 2022-07-31 | 2022-09-22 | |
| Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis Pirfenidone Capsules, placebo capsules - Pneumoconiosis | Phase 3 | Recruiting | Beijing Continent Pharmaceutical Co, Ltd. | 272 | 2022-06-07 | 2025-11-24 |
| The SHIELD Whole Lung Lavage Study Whole Lung Lavage - Silicosis | Unknown | The University of Queensland | 30 | 2022-06-01 | 2022-06-02 | |
| Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy None, pure observational study - Cerebral Amyloid Angiopathy, Siderosis | Completed | Centre Hospitalier Universitaire de Nīmes | 111 | 2022-06-01 | 2025-12-04 | |
| KAP TB in Senior Management Officials of Companies With Increased Silica Exposure TB - Tuberculosis, Silicosis | Completed | Centre for Infectious Disease Research in Zambia | 118 | 2022-02-02 | 2026-08-06 | |
| FAPI PET for Lung Fibrosis 68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias | Early Phase 1 | Active not recruiting | University of California, Los Angeles | 30 | 2021-11-16 | 2026-08-20 |
| Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis Pirfenidone Oral Tablet - Silicosis, Progressive Massive Fibrosis | Phase 2 | Unknown | Instituto de investigación e innovación biomédica de Cádiz | 18 | 2021-11-15 | 2022-01-13 |
| Pneumoconiosis and Dust Exposure China Cohort Pneumoconiosis | Recruiting | China-Japan Friendship Hospital | 2000 | 2021-05-28 | 2025-07-22 | |
| TCM for Coal Worker's Pneumoconiosis Chinese medicine compound combined with symptomatic treatments, Chinese medicine compound placebo combined with symptomatic treatments - Coal Worker's Pneumoconiosis | Not applicable | Unknown | Henan University of Traditional Chinese Medicine | 222 | 2021-04-15 | 2021-04-12 |
| Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages Blood collection, Blood sample - History of Exposure to Silica or Asbestosis, Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases | Not applicable | Completed | Rennes University Hospital | 23 | 2021-03-31 | 2022-01-04 |
Showing 20 of 46. Sign in to see all of them.
Silicosis (19) · Asbestosis (8) · Anthracosis (4) · Lung Diseases, Interstitial (4) · Siderosis (4) · Berylliosis (3) · Pulmonary Disease, Chronic Obstructive (3) · Tuberculosis (3) · Bronchiectasis (2) · Hypertension, Pulmonary (2) · Idiopathic Pulmonary Fibrosis (2) · Lung Diseases (2) · Pulmonary Fibrosis (2) · Alveolitis, Extrinsic Allergic (1)
Lung Injury (46) · Respiratory Tract Diseases (46) · Lung Diseases (44) · Lung Diseases, Interstitial (42) · Occupational Diseases (42) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Actinomycetales Infections (4) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Disease Attributes (4) · Gram-Positive Bacterial Infections (4) · Immune System Diseases (4) · Mycobacterium Infections (4)
pirfenidone (4) · Surveys and Questionnaires (2) · Blood Specimen Collection (1) · Cell Count (1) · Control Groups (1) · Convolutional Neural Networks (1) · Diagnostic Imaging (1) · FAPI-46 (1) · Infliximab (1) · Isoniazid (1) · Magnetic Resonance Spectroscopy (1) · Medication Therapy Management (1) · Mesalamine (1) · N95 Respirators (1) · Nicotine Replacement Therapy (1)
Chinese University of Hong Kong (4) · National Jewish Health (2) · Peking University Third Hospital (2) · Rio de Janeiro State University (2) · Tel-Aviv Sourasky Medical Center (2) · The University of Queensland (2) · Aga Khan University (1) · Beijing Continent Pharmaceutical Co, Ltd. (1) · Cairo University (1) · Centre Hospitalier Universitaire de Nīmes (1) · Centre for Infectious Disease Research in Zambia (1) · China-Japan Friendship Hospital (1) · GCS Ramsay Santé pour l'Enseignement et la Recherche (1) · HOHM Foundation (1) · Henan University of Traditional Chinese Medicine (1)
United States (10) · China (9) · Australia (3) · Brazil (3) · France (3) · Canada (2) · Hong Kong (2) · Israel (2) · Nepal (1) · Pakistan (1) · Rwanda (1) · Spain (1) · Tanzania (1) · United Kingdom (1) · Zambia (1)
Daniel Chambers (2) · Yehuda Shwartz, MD (2) · Alastair C Gray, PhD (1) · Antonio Campos Caro, phD (1) · Asaad A Nafees (1) · Brian Day, PhD (1) · David J Werring, Professor (1) · Deborah Yates, A/Prof (1) · Doris-Eva Bamiou, Professor (1) · Drew Harris, MD (1) · Emory Robinette, MD (1) · Guo Q Li, Professor (1) · Hans Weill (1)
PMID 12371452, PMID 17296674, PMID 22974830, PMID 23778400, PMID 24685414, PMID 26059242, PMID 26400297, PMID 28195659, PMID 28514023, PMID 31576609, PMID 31770617, PMID 32553881, PMID 33774816, PMID 33798455, PMID 34042560, PMID 34791042, PMID 34799440, PMID 35584850, PMID 35688625, PMID 35762891, PMID 35918725, PMID 35987988, PMID 36717255, PMID 36878206, PMID 37857425, PMID 39362770, PMID 40320069, PMID 41215782, PMID 42481393, PMID 42599106
1UL1RR025780 (1), D43TW009340 (1), P30CA044579 (1), P50HL015092 (1), R21HL081766 (1)